Works by Okubo, Tomomi

Results: 47
    1

    Association Between Laboratory Values and Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis: A Multicenter, Retrospective Study.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 6, p. 1858, doi. 10.3390/jcm14061858
    By:
    • Koyano, Kaori;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Miwa, Takao;
    • Namisaki, Tadashi;
    • Hiraoka, Atsushi;
    • Toyoda, Hidenori;
    • Tada, Toshifumi;
    • Kobayashi, Yuji;
    • Kawata, Kazuhito;
    • Matsuura, Kentaro;
    • Mikami, Shigeru;
    • Kawabe, Naoto;
    • Oikawa, Tsunekazu;
    • Suzuki, Kenta;
    • Kawano, Tadamichi;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Tani, Joji
    Publication type:
    Article
    2

    Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 8, doi. 10.1159/000539380
    By:
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Kobayashi, Kazufumi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Obu, Masamichi;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Yumita, Sae;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Nagashima, Kengo;
    • Itobayashi, Ei
    Publication type:
    Article
    3

    Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 473, doi. 10.1159/000515552
    By:
    • Koroki, Keisuke;
    • Kanogawa, Naoya;
    • Maruta, Susumu;
    • Ogasawara, Sadahisa;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Maeda, Takahiro;
    • Inoue, Masanori;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Okabe, Shinichiro;
    • Koma, Yoshihiro;
    • Azemoto, Ryosaku;
    • Atsukawa, Masanori;
    • Itobayashi, Ei;
    • Ito, Kenji;
    • Sugiura, Nobuyuki;
    • Mizumoto, Hideaki
    Publication type:
    Article
    4

    Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 473, doi. 10.1159/000515552
    By:
    • Koroki, Keisuke;
    • Kanogawa, Naoya;
    • Maruta, Susumu;
    • Ogasawara, Sadahisa;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Maeda, Takahiro;
    • Inoue, Masanori;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Okabe, Shinichiro;
    • Koma, Yoshihiro;
    • Azemoto, Ryosaku;
    • Atsukawa, Masanori;
    • Itobayashi, Ei;
    • Ito, Kenji;
    • Sugiura, Nobuyuki;
    • Mizumoto, Hideaki
    Publication type:
    Article
    5

    Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction‐associated steatotic liver disease: A prospective, multicentre, observational study.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4958, doi. 10.1111/dom.15898
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Oikawa, Tsunekazu;
    • Tada, Toshifumi;
    • Matsuura, Kentaro;
    • Ishikawa, Toru;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Morishita, Asahiro;
    • Tani, Joji;
    • Okubo, Tomomi;
    • Nagao, Mototsugu;
    • Iwabu, Masato;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    6

    Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data.

    Published in:
    Therapeutic Advances in Endocrinology & Metabolism, 2021, p. 1, doi. 10.1177/20420188211000243
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Mikami, Shigeru;
    • Ono, Hiroki;
    • Kawano, Tadamichi;
    • Yoshida, Yuji;
    • Tanabe, Tomohide;
    • Okubo, Tomomi;
    • Hayama, Korenobu;
    • Nakagawa-Iwashita, Ai;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Kaneko, Keiko;
    • Emoto, Naoya;
    • Nagao, Mototsugu;
    • Inagaki, Kyoko;
    • Fukuda, Izumi;
    • Sugihara, Hitoshi;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    7
    8

    Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.

    Published in:
    PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0224184
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kawano, Tadamichi;
    • Koeda, Mai;
    • Yoshida, Yuji;
    • Tanabe, Tomohide;
    • Okubo, Tomomi;
    • Hayama, Korenobu;
    • Iwashita, Ai;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Kaneko, Keiko;
    • Kawamoto, Chiaki;
    • Hatori, Tsutomu;
    • Emoto, Naoya;
    • Iio, Etsuko;
    • Tanaka, Yasuhito;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    9

    Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment.

    Published in:
    Current Oncology, 2022, v. 29, n. 5, p. 3259, doi. 10.3390/curroncol29050266
    By:
    • Chuma, Makoto;
    • Yokoo, Hideki;
    • Hiraoka, Atsushi;
    • Ueda, Kazuhiko;
    • Yokoyama, Takahiro;
    • Tsuji, Kunihiko;
    • Shimada, Noritomo;
    • Uojima, Haruki;
    • Kobayashi, Satoshi;
    • Hattori, Nobuhiro;
    • Okubo, Tomomi;
    • Atsukawa, Masanori;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Tsutsui, Akemi;
    • Toyoda, Hidenori;
    • Tada, Toshifumi;
    • Saito, Yoshinori;
    • Hirose, Shunji;
    • Tanaka, Takaaki
    Publication type:
    Article
    10
    11

    Impact of pemafibrate in patients with metabolic dysfunction‐associated steatotic liver disease complicated by dyslipidemia: A single‐arm prospective study.

    Published in:
    JGH Open, 2024, v. 8, n. 4, p. 1, doi. 10.1002/jgh3.13057
    By:
    • Ono, Hiroki;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Arai, Taeang;
    • Suzuki, Kenta;
    • Higashi, Tetsuyuki;
    • Kitamura, Michika;
    • Shioda‐Koyano, Kaori;
    • Kawano, Tadamichi;
    • Yoshida, Yuji;
    • Okubo, Tomomi;
    • Hayama, Korenobu;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Nagao, Mototsugu;
    • Iwabu, Masato;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    12

    How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis.

    Published in:
    JGH Open, 2023, v. 7, n. 8, p. 588, doi. 10.1002/jgh3.12949
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Tamura, Yuichi;
    • Koyano‐Shioda, Kaori;
    • Kawano, Tadamichi;
    • Okubo, Tomomi;
    • Hayama, Korenobu;
    • Arai, Taeang;
    • Itokawa, Norio;
    • Taniguchi, Yu;
    • Tamura, Yudai;
    • Kondo, Chisa;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    13
    14

    Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.

    Published in:
    Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 513, doi. 10.1007/s40801-023-00379-x
    By:
    • Kanzaki, Hiroaki;
    • Ogasawara, Sadahisa;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Yoshino, Ryohei;
    • Fujimoto, Kentaro;
    • Kogure, Tadayoshi;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Iwanaga, Terunao;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Kojima, Ryuta;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato
    Publication type:
    Article
    15

    Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 4, p. 590, doi. 10.1002/cncr.34559
    By:
    • Nakagawa, Miyuki;
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Kikuchi, Yasuharu;
    • Kogure, Tadayoshi;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kojima, Ryuta
    Publication type:
    Article
    16

    Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice.

    Published in:
    BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02731-5
    By:
    • Yumita, Sae;
    • Ogasawara, Sadahisa;
    • Nakagawa, Miyuki;
    • Maruta, Susumu;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Kogure, Tadayoshi;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke
    Publication type:
    Article
    17
    18

    Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real‐world setting: A large, multicenter study from Japan.

    Published in:
    Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1420, doi. 10.1111/jgh.14982
    By:
    • Toyoda, Hidenori;
    • Atsukawa, Masanori;
    • Watanabe, Tsunamasa;
    • Nakamuta, Makoto;
    • Uojima, Haruki;
    • Nozaki, Akito;
    • Takaguchi, Koichi;
    • Fujioka, Shinichi;
    • Iio, Etsuko;
    • Shima, Toshihide;
    • Akahane, Takehiro;
    • Fukunishi, Shinya;
    • Asano, Toru;
    • Michitaka, Kojiro;
    • Tsuji, Kunihiko;
    • Abe, Hiroshi;
    • Mikami, Shigeru;
    • Okubo, Hironao;
    • Okubo, Tomomi;
    • Shimada, Noritomo
    Publication type:
    Article
    19

    Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.

    Published in:
    Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 5, p. 855, doi. 10.1111/jgh.14874
    By:
    • Toyoda, Hidenori;
    • Atsukawa, Masanori;
    • Watanabe, Tsunamasa;
    • Nakamuta, Makoto;
    • Uojima, Haruki;
    • Nozaki, Akito;
    • Takaguchi, Koichi;
    • Fujioka, Shinichi;
    • Iio, Etsuko;
    • Shima, Toshihide;
    • Akahane, Takehiro;
    • Fukunishi, Shinya;
    • Asano, Toru;
    • Michitaka, Kojiro;
    • Tsuji, Kunihiko;
    • Abe, Hiroshi;
    • Mikami, Shigeru;
    • Okubo, Hironao;
    • Okubo, Tomomi;
    • Shimada, Noritomo
    Publication type:
    Article
    20

    Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.

    Published in:
    Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 2, p. 364, doi. 10.1111/jgh.14447
    By:
    • Atsukawa, Masanori;
    • Kondo, Chisa;
    • Iwakiri, Katsuhiko;
    • Asano, Toru;
    • Ishikawa, Toru;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Tsuji, Kunihiko;
    • Ogawa, Chikara;
    • Shimada, Noritomo;
    • Iio, Etsuko;
    • Tanaka, Yasuhito;
    • Mikami, Shigeru;
    • Tsubota, Akihito;
    • Matsumoto, Yoshihiro;
    • Toyoda, Hidenori;
    • Kumada, Takashi;
    • Takaguchi, Koichi;
    • Okubo, Tomomi;
    • Hiraoka, Atsushi
    Publication type:
    Article
    21

    Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.

    Published in:
    Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 6, p. 1256, doi. 10.1111/jgh.14047
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kato, Keizo;
    • Abe, Hiroshi;
    • Shimada, Noritomo;
    • Asano, Toru;
    • Ikegami, Tadashi;
    • Koeda, Mai;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Nakagawa‐Iwashita, Ai;
    • Yoshida, Yuji;
    • Hayama, Korenobu;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Chuganji, Yoshimichi;
    • Matsuzaki, Yasushi;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    22

    Esophageal Varices as an Independent Predictor of Fatal Outcomes after Balloon-Occluded Retrograde Transvenous Obliteration in Patients with Hepatic Encephalopathy.

    Published in:
    Digestive Diseases, 2024, v. 42, n. 6, p. 583, doi. 10.1159/000541660
    By:
    • Iwasaki, Shuichiro;
    • Uojima, Haruki;
    • Sakita, Shinya;
    • Masuda, Sakue;
    • Kubota, Kousuke;
    • Fujikawa, Tomoaki;
    • Okubo, Tomomi;
    • Setsu, Toru;
    • Itokawa, Norio;
    • Furuichi, Yoshihiro;
    • Arase, Yoshitaka;
    • Tukiyama, Toshiki;
    • Fujii, Kaoru;
    • Hidaka, Hisashi;
    • Atsukawa, Masanori;
    • Kagawa, Tatehiro;
    • Kako, Makoto;
    • Terai, Shuji;
    • Kusano, Chika
    Publication type:
    Article
    23

    Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).

    Published in:
    Investigational New Drugs, 2024, v. 42, n. 4, p. 394, doi. 10.1007/s10637-024-01441-3
    By:
    • Kobayashi, Kazufumi;
    • Ogasawara, Sadahisa;
    • Itobayashi, Ei;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Nakamura, Kazuyoshi;
    • Moriguchi, Michihisa;
    • Watanabe, Shunji;
    • Ikeda, Masafumi;
    • Kuroda, Hidekatsu;
    • Kawaoka, Tomokazu;
    • Hiraoka, Atsushi;
    • Yasui, Yutaka;
    • Kuzuya, Teiji;
    • Sato, Rui;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Nakamura, Masato;
    • Kiyono, Soichiro
    Publication type:
    Article
    24
    25

    Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan.

    Published in:
    2018
    By:
    • Toyoda, Hidenori;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Senoh, Tomonori;
    • Michitaka, Kojiro;
    • Hiraoka, Atsushi;
    • Fujioka, Shinichi;
    • Kondo, Chisa;
    • Okubo, Tomomi;
    • Uojima, Haruki;
    • Tada, Toshifumi;
    • Yoneyama, Hirohito;
    • Watanabe, Tsunamasa;
    • Asano, Toru;
    • Ishikawa, Toru;
    • Tamai, Hideyuki;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Tsuji, Kunihiko;
    • Ogawa, Chikara
    Publication type:
    journal article
    26

    Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial.

    Published in:
    Nutrients, 2021, v. 13, n. 6, p. 1874, doi. 10.3390/nu13061874
    By:
    • Okubo, Tomomi;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Ono, Hiroki;
    • Kawano, Tadamichi;
    • Yoshida, Yuji;
    • Arai, Taeang;
    • Hayama, Korenobu;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Kaneko, Keiko;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    27

    Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C.

    Published in:
    Journal of Medical Virology, 2015, v. 87, n. 11, p. 1904, doi. 10.1002/jmv.24244
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Shimada, Noritomo;
    • Abe, Hiroshi;
    • Itokawa, Norio;
    • Nakagawa, Ai;
    • Okubo, Tomomi;
    • Aizawa, Yoshio;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    28

    Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2025, v. 55, n. 5, p. 718, doi. 10.1111/hepr.14160
    By:
    • Yonemoto, Takuya;
    • Ogasawara, Sadahisa;
    • Kanogawa, Naoya;
    • Miwa, Chihiro;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Yumita, Sae;
    • Nakagawa, Miyuki;
    • Okubo, Tomomi;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Itobayashi, Ei
    Publication type:
    Article
    29

    Cell‐free and concentrated ascites reinfusion therapy versus large‐volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.

    Published in:
    Hepatology Research, 2023, v. 53, n. 3, p. 238, doi. 10.1111/hepr.13860
    By:
    • Hanai, Tatsunori;
    • Kawaratani, Hideto;
    • Nagano, Junji;
    • Suii, Hirokazu;
    • Sakamaki, Akira;
    • Arase, Yoshitaka;
    • Nakanishi, Hiroyuki;
    • Kogiso, Tomomi;
    • Okubo, Tomomi;
    • Miwa, Takao;
    • Shimizu, Shogo;
    • Hige, Shuhei;
    • Atsukawa, Masanori;
    • Shimizu, Masahito;
    • Kurosaki, Masayuki;
    • Terai, Shuji;
    • Kagawa, Tatehiro;
    • Tokushige, Katsutoshi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    30

    Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterization.

    Published in:
    Hepatology Research, 2020, v. 50, n. 11, p. 1244, doi. 10.1111/hepr.13560
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Hatano, Masaru;
    • Kondo, Chisa;
    • Shioda, Kaori;
    • Ohno, Hiroki;
    • Kawano, Tadamichi;
    • Hayama, Korenobu;
    • Arai, Taeang;
    • Nakagawa‐Iwashita, Ai;
    • Itokawa, Norio;
    • Kaneko, Keiko;
    • Yoshida, Yuji;
    • Koeda, Mai;
    • Okubo, Tomomi;
    • Yamamoto, Teppei;
    • Yamamoto, Takeshi;
    • Taniai, Nobuhiko;
    • Yoshida, Hiroshi;
    • Kanazawa, Hidenori
    Publication type:
    Article
    31
    32

    Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan.

    Published in:
    Hepatology Research, 2019, v. 49, n. 4, p. 369, doi. 10.1111/hepr.13292
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Toyoda, Hidenori;
    • Takaguchi, Koichi;
    • Nakamuta, Makoto;
    • Watanabe, Tsunamasa;
    • Tada, Toshifumi;
    • Tsutsui, Akemi;
    • Ikeda, Hiroki;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Uojima, Haruki;
    • Ikegami, Tadashi;
    • Asano, Toru;
    • Kondo, Chisa;
    • Koeda, Mai;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Iwashita‐Nakagawa, Ai;
    • Itokawa, Norio
    Publication type:
    Article
    33

    Efficacy of direct‐acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study.

    Published in:
    Hepatology Research, 2019, v. 49, n. 2, p. 125, doi. 10.1111/hepr.13256
    By:
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Ikegami, Tadashi;
    • Shimada, Noritomo;
    • Kato, Keizo;
    • Abe, Hiroshi;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Iwashita, Ai‐Nakagawa;
    • Kondo, Chisa;
    • Mikami, Shigeru;
    • Asano, Toru;
    • Matsuzaki, Yasushi;
    • Toyoda, Hidenori;
    • Kumada, Takashi;
    • Iio, Etsuko;
    • Tanaka, Yasuhito;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    34

    Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease.

    Published in:
    Hepatology Research, 2018, v. 48, n. 7, p. 549, doi. 10.1111/hepr.13058
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Ikegami, Tadashi;
    • Shimada, Noritomo;
    • Kato, Keizo;
    • Abe, Hiroshi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Mikami, Shigeru;
    • Asano, Toru;
    • Chuganji, Yoshimichi;
    • Matsuzaki, Yasushi;
    • Toyoda, Hidenori;
    • Kumada, Takashi;
    • Iio, Etsuko;
    • Tanaka, Yasuhito;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    35

    Serum <italic>Wisteria floribunda</italic> agglutinin‐positive Mac‐2 binding protein more reliably distinguishes liver fibrosis stages in non‐alcoholic fatty liver disease than serum Mac‐2 binding protein.

    Published in:
    Hepatology Research, 2018, v. 48, n. 6, p. 424, doi. 10.1111/hepr.13046
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Nakagawa, Ai;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Kato, Keizo;
    • Hatori, Tsutomu;
    • Hano, Hiroshi;
    • Oikawa, Tsunekazu;
    • Emoto, Naoya;
    • Abe, Masanori;
    • Kage, Masayoshi;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    36

    Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C.

    Published in:
    Hepatology Research, 2017, v. 47, n. 13, p. 1429, doi. 10.1111/hepr.12910
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Koushima, Yohei;
    • Ikegami, Tadashi;
    • Watanabe, Kouji;
    • Shimada, Noritomo;
    • Sato, Shinichi;
    • Kato, Keizo;
    • Abe, Hiroshi;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Mikami, Shigeru;
    • Asano, Toru;
    • Chuganji, Yoshimichi;
    • Matsuzaki, Yasushi;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    37
    38
    39

    Effect of native vitamin D<sub>3</sub> supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin.

    Published in:
    Hepatology Research, 2016, v. 46, n. 5, p. 450, doi. 10.1111/hepr.12575
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Shimada, Noritomo;
    • Yoshizawa, Kai;
    • Abe, Hiroshi;
    • Asano, Toru;
    • Ohkubo, Yusuke;
    • Araki, Masahiro;
    • Ikegami, Tadashi;
    • Okubo, Tomomi;
    • Kondo, Chisa;
    • Osada, Yuji;
    • Nakatsuka, Katsuhisa;
    • Chuganji, Yoshimichi;
    • Matsuzaki, Yasushi;
    • Iwakiri, Katsuhiko;
    • Aizawa, Yoshio
    Publication type:
    Article
    40
    41
    42
    43

    Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11431-1
    By:
    • Kawano, Tadamichi;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Shimada, Noritomo;
    • Toyoda, Hidenori;
    • Takaguchi, Koichi;
    • Tani, Joji;
    • Morishita, Asahiro;
    • Hiraoka, Atsushi;
    • Mikami, Shigeru;
    • Ishikawa, Toru;
    • Okubo, Hironao;
    • Watanabe, Tsunamasa;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Hayama, Korenobu;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    44

    Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-95581-8
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kato, Keizo;
    • Abe, Hiroshi;
    • Ono, Hirotaka;
    • Kawano, Tadamichi;
    • Yoshida, Yuji;
    • Tanabe, Tomohide;
    • Okubo, Tomomi;
    • Hayama, Korenobu;
    • Nakagawa-Iwashita, Ai;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Kaneko, Keiko;
    • Emoto, Naoya;
    • Nagao, Mototsugu;
    • Inagaki, Kyoko;
    • Fukuda, Izumi;
    • Sugihara, Hitoshi
    Publication type:
    Article
    45

    A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C.

    Published in:
    PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257166
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Uchida-Kobayashi, Sawako;
    • Takaguchi, Koichi;
    • Tsutsui, Akemi;
    • Nozaki, Akito;
    • Chuma, Makoto;
    • Hidaka, Isao;
    • Ishikawa, Tsuyoshi;
    • Iwasa, Motoh;
    • Tamai, Yasuyuki;
    • Tobari, Maki;
    • Matsuura, Kentaro;
    • Nagura, Yoshihito;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Suzuki, Kenta;
    • Okubo, Tomomi;
    • Arai, Taeang
    Publication type:
    Article
    46
    47

    Risk Stratification for Malignant Potential of Intraductal Papillary Mucinous Neoplasms Using the Apolipoprotein-A2 Isoforms Blood Test.

    Published in:
    Clinical & Translational Gastroenterology, 2025, v. 16, n. 6, p. e00856, doi. 10.14309/ctg.0000000000000856
    By:
    • Hasegawa, Yuta;
    • Itokawa, Norio;
    • Kashiro, Ayumi;
    • Kitamura, Michika;
    • Nagashima, Kengo;
    • Suzuki, Kenta;
    • Higashi, Tetsuyuki;
    • Shioda-Koyano, Kaori;
    • Ono, Hiroki;
    • Kawano, Tadamichi;
    • Yoshida, Yuji;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Hayama, Korenobu;
    • Kaneko, Keiko;
    • Atsukawa, Masanori;
    • Takeuchi, Keiko;
    • Futagami, Seiji;
    • Iwakiri, Katsuhiko;
    • Honda, Kazufumi
    Publication type:
    Article